SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals more than 17,000, including physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from 76 countries around the world.
Attend the 2018 SNMMI Mid-Winter and ACNM Annual Meeting, taking place January 25-27, 2018 in Orlando, FL, and connect with leading experts in the field, ready to provide you insight into best practices in clinical applications, and updates on cutting-edge research. With more than 50 presentations to choose from, you can create the event that's perfect for you! Highlights include theranostics focused track, and informative presentations.
Online registration deadline: January 18, 2018
Make plans to attend the AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, taking place February 14-17, 2018 in San Diego, CA.
The collaborative meeting program will allow you to connect directly with the profession's foremost experts on the latest topics in Molecular Imaging in Cancer Biology and Therapy.
SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals over 20,000, which includes physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from more than 84 countries around the world. SNMMI's Journal of Nuclear Medicine (JNM), the premier international journal of nuclear medicine, reaches over 17,000 individuals each month. SNMMI's Annual Meeting is nuclear medicine's and molecular imaging's largest gathering each year, attracting over 5,000 professional attendees and another 2,500 industry representatives.
At the most recent Annual Meeting in June 2016 in San Diego, California, 35% of registered attendees were from countries other than the United States. Attendees represented over 65 countries. In addition, abstract submissions for SNMMI's Annual Meeting from outside the United States represent close to 67% of all submissions.
While SNMMI's headquarters office resides in Virginia, just outside of Washington, D.C., its perspective, programs, and growth are as international as its members. As of 2017, 12% of the Society's members reside in more than 84 countries other than the United States.
Search for an international nuclear medicine and molecular imaging organization near you.
SNMMI's educational programs and activities reflect the increasing importance and participation of its international members. Such common global nuclear medicine and molecular imaging and therapy issues as quality of care, educating referring physicians and patients, and exploring ways to better share developments in the practice of nuclear medicine and molecular imaging and therapy are but a few of the activities currently underway by Society staff, Committees, Councils, and our Centers of Excellence. This website seeks to constantly expand its offerings to the Society's international members, providing an ever-changing, updated array of global resources and news for nuclear medicine and molecular imaging and therapy professionals literally anywhere on the globe.
SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting. These joint sponsored programs include not only the sharing of speakers and renown experts on all facets of nuclear medicine and molecular imaging, collaboration on the development of enduring educational materials, and programmatic/administrative support, but also include translation of materials and website development.
Each year, the SNMMI collaborates with international organizations in an effort to continue the exchange of ideas, education and knowledge. Intiatives include:
Nuclear Medicine Global Initiative
3rd Sino-American Conference
Chinese/U.S. Resident Exchange Program
IAEA CT Case Webinar Series
EANM Collaborative Guidelines
SNMMI offers a Full International Membership category for international colleagues. Learn more on how to become an SNMMI Full Member (international).
Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine. This includes the diagnostic, therapeutic or investigational use of radionuclides or other molecular imaging technologies.
Annual dues: $510
Includes subscription to The Journal of Nuclear Medicine.
Includes voting rights and can be elected an Officer of the SNMMI.
Corresponding Country Discount
In an effort to make membership more accessible to nuclear medicine and molecular imaging professionals around the world, SNMMI’s corresponding country category gives members of eligible countries an 80% discount on dues. See discount breakdown.
80% discount on all membership categories
Online access to The Journal of Nuclear Medicine.
Voting rights and can be elected an Officer of the SNMMI.
As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States. These strategic alliances stretch across the globe. reaching every continent where SNMMI's members reside and practice.
SNMMI Partners and Alliances Include:
For more information on SNMMI's international activities and programs, please contact:
Nikki Wenzel-Lamb, MBA Director of Leadership Direct: 703-652-6766 Fax: 703-708-9020 Email: email@example.com
Dopamine transporter (DaT) imaging, with single-photon emission computed tomography (SPECT), is used to diagnose Parkinson’s disease. To help patients who are scheduled for a DaT SPECT procedure, SNMMI’s Brain Imaging Outreach Working Group created a video that takes the patient through what happens at each step.
On March 30, 2018, Aetna issued a revised PET coverage policy that failed to cover Dotatate and Fluciclovine. SNMMI requests that it change these policies.
(Government Relations News)
SNMMI and the Education and Research Foundation for Nuclear Medicine and Molecular Imaging are pleased to announce that Aria Razmaria, MD, has been selected as the recipient of the 2018 Robert E. Henkin Government Relations Fellowship.
(Government Relations News)
A PET imaging agent could show, ahead of time, whether a specific treatment is likely to be effective for major depressive disorder—a debilitating condition that affects more than 14 million Americans. No such marker is currently available in clinical psychiatry. The study is featured in the April issue of The Journal of Nuclear Medicine.
Present Your Research. Increase Your Professional Recognition.
Distinguish yourself from your peers and earn the opportunity to present your original research to an international audience of leading nuclear medicine and molecular imaging professionals at the SNMMI 2018 Annual Meeting, June 23-26, 2018 in Philadelphia, Pennsylvania, USA.
Submit your abstract.
Abstract submission deadline: January 9, 2018
Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.